This website uses cookies to improve functionality and performance. With a click on the OK button you are giving implied consent to the use of cookies on this website.
More information
Login Environment Pharma

Phase I - Analytics

Your local laboratory – supporting over 1,800 Phase I studies since 1993.
In addition, in order to locally support your regional studies in case you need immediate lab testing and result reporting, SYNLAB pharma can support you with over 200 SYNLAB laboratories in Europe and Middle East. Hence, SYNLAB pharma can provide a fast response for safety testing and other time critical assays.

Other services are also available to support Phase I studies:

In addition, we can provide local Project Management to support volunteer selection, monitoring and special sample collection (PK/PD).

Once your drug goes into Phase II and III studies you do not need to search for another laboratory partner:  SYNLAB pharma can provide the logistical support through our own central laboratory with global capacities.

Contact us


View All
Fellbach wird neuer Laborstandort
Nach zweijähriger Planungs- und Umbauphase entstand in Fellbach das neue Labor der SYNLAB Analytics & Services Germany GmbH.
Aug 10, 2018 Continue
Determination of the Impurity N-Nitroso dimethyl amine (NDMA) in Drug Substances with GC-MS

Due to contamination of a drug substance with the potential mutagenic substance N-Nitroso dimethyl amine (NDMA) a massive recall campaign was initiated for the related drug products. SYNLAB Pharma offers a GC-MS test for testing the absence of NDMA in drug substances and drug products.

Please contact our experts.

Jul 13, 2018 | Pharma Continue
New Services in Regulatory Compliance for Biologics

With immediate effect, SYNLAB Pharma provides a broad support in the field of Regulatory Compliance of Biologics development. With this new services we support specifically start-ups, small to medium sized biotech companies, which require professional consultancy and project execution in regulatory project design.

For further questions, please contact:

Jun 18, 2018 | Pharma Continue
View All